Blau Farmacêutica S.A. (BVMF:BLAU3)
Brazil · Delayed Price · Currency is BRL 9.62
-0.18 (-1.84%)
At close: Mar 20, 2026
Blau Farmacêutica Cash Flow Statement
Financials in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 294.96 | 217.21 | 249.81 | 363.37 | 325.22 |
Depreciation & Amortization | 69.41 | 47.58 | 36.33 | 20.7 | 19.94 |
Other Amortization | - | 4.18 | 2.56 | 1.59 | 0.97 |
Asset Writedown & Restructuring Costs | 6.26 | 4.89 | 1.11 | 14.08 | -20.03 |
Loss (Gain) From Sale of Investments | - | - | - | -59.79 | -34.27 |
Loss (Gain) on Equity Investments | - | - | -0.16 | - | - |
Provision & Write-off of Bad Debts | 3.8 | 14.69 | 9.43 | 0.01 | -2.13 |
Other Operating Activities | 131.26 | 118.76 | -73.35 | 69.02 | 61.42 |
Change in Accounts Receivable | 3.26 | -26.03 | -1.07 | -88.49 | -83.25 |
Change in Inventory | -135.85 | -6.28 | 24.73 | -160.4 | -93.63 |
Change in Accounts Payable | -8.56 | 90.51 | -13.56 | 46.63 | -18.99 |
Change in Income Taxes | 24.89 | -21.83 | -35 | -54.79 | -12.26 |
Change in Other Net Operating Assets | -98.57 | 63.54 | 19.73 | 19.99 | 11.13 |
Operating Cash Flow | 290.84 | 507.2 | 220.56 | 171.9 | 154.13 |
Operating Cash Flow Growth | -42.66% | 129.96% | 28.31% | 11.53% | -31.04% |
Capital Expenditures | -262.04 | -142.67 | -149.42 | -142.66 | -148.2 |
Cash Acquisitions | - | - | -136.6 | - | - |
Sale (Purchase) of Intangibles | -156.71 | -141.15 | -114.97 | -37.48 | -29.58 |
Investment in Securities | -66.51 | -30.9 | 44.19 | 313.1 | -692.55 |
Investing Cash Flow | -154.73 | -314.72 | -356.81 | 132.96 | -870.32 |
Short-Term Debt Issued | - | - | - | - | 155.3 |
Long-Term Debt Issued | 92.11 | - | 350 | - | - |
Total Debt Issued | 92.11 | - | 350 | - | 155.3 |
Short-Term Debt Repaid | - | - | - | -40.93 | -131.02 |
Long-Term Debt Repaid | -58.89 | -55.88 | -76.77 | -47.69 | -386.26 |
Total Debt Repaid | -58.89 | -55.88 | -76.77 | -88.62 | -517.28 |
Net Debt Issued (Repaid) | 33.21 | -55.88 | 273.23 | -88.62 | -361.98 |
Issuance of Common Stock | - | - | - | - | 1,216 |
Repurchase of Common Stock | - | - | -3 | -39.9 | - |
Common Dividends Paid | -82 | -56.11 | -66.16 | -135.52 | -104.13 |
Other Financing Activities | -71.52 | -78.67 | -50.44 | -78.58 | -51.99 |
Financing Cash Flow | -120.31 | -190.67 | 153.63 | -342.62 | 697.86 |
Foreign Exchange Rate Adjustments | -3.53 | - | - | - | - |
Net Cash Flow | 12.28 | 1.82 | 17.38 | -37.75 | -18.33 |
Free Cash Flow | 28.8 | 364.53 | 71.14 | 29.24 | 5.93 |
Free Cash Flow Growth | -92.10% | 412.43% | 143.26% | 392.80% | -95.88% |
Free Cash Flow Margin | 1.69% | 20.78% | 5.18% | 2.08% | 0.43% |
Free Cash Flow Per Share | - | 1.58 | 0.31 | 0.13 | 0.03 |
Cash Interest Paid | - | 76.88 | 35.64 | 37.73 | 25.97 |
Cash Income Tax Paid | - | 11.96 | 25.12 | 74.57 | 134.95 |
Levered Free Cash Flow | -271.8 | 110.19 | -104.4 | -117.83 | -125.96 |
Unlevered Free Cash Flow | -208.44 | 146.64 | -84.33 | -97.57 | -109.21 |
Change in Working Capital | -214.85 | 99.91 | -5.17 | -237.07 | -197 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.